When was iLoF founded?

iLoF was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is iLoF located?

iLoF is headquartered in Porto, Portugal.

How many employees does iLoF have?

As of Oct 31, 2026, the latest employee count at iLoF is 42.

Is iLoF a funded company?

iLoF is a funded company, having raised a total of $5.09M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Nov 28, 2019.

When was the latest funding round of iLoF?

iLoF's latest funding was a $***** Grant (prize money) round on 2023, with participation from 1 investor.

Where does iLoF rank among its competitors?

iLoF ranks 32nd amongst 282 active competitors, of which 86 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Tandem AI, which secured $22M in Nov, 2025.

Who are the top competitors of iLoF?

iLoF's top competitors include Schrodinger, Recursion Pharmaceuticals and Relay Therapeutics. Among them, Tandem AI secured the most recent funding round in November, 2025.

iLoF - 2026 Company Profile, Team, Funding & Competitors

iLoF is a series A company based in Porto (Portugal), founded in 2019 by Joana S Paiva. It operates as a Developer of therapeutics for Alzheimer's disease. iLoF has raised $5.09M in funding from investors like Mayfield, M12 and Faber. The company has 282 active competitors, including 86 funded and 15 that have exited. Its top competitors include companies like Schrodinger, Recursion Pharmaceuticals and Relay Therapeutics.

Company Details

Developer of therapeutics for Alzheimer's disease. The company is developing Alzheimer’s drug discovery using bio-photonics and AI technology. The company uses AI to reduce the cost of clinical trials. It also offers PET and lumbar puncture for invasiveness and inconvenience of screening procedures.

Website: ilof.tech
Social
Email ID: *****@ilof.tech
Phone Number: +351 **********

Key Metrics

Founded Year

2019

Location

Porto, Portugal

Stage

Series A

Total Funding

$5.09M in 7 rounds

Latest Funding Round

Grant (prize money), 2023, $*****

Investors

Mayfield & 16 more

Ranked

32^nd among 282 active competitors

Employee Count

42 as on Oct 31, 2026

Similar Companies

Schrodinger & 288 more

View iLoF's full profile

iLoF has raised a total funding of $5.09M over 7 rounds. Its first funding round was on Nov 28, 2019. Its latest funding round was a Grant (prize money) round on 2023 for $*****. 1 investor participated in its latest round. iLoF has 16 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of iLoF:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2023	7088	Grant (prize money)	1800	8580	3612	6626
Jan 19, 2023	2104656	Grant (prize money)	5424263	7916984	2731252	Europa
Jul 28, 2022	7692260	Series A	5581683	7420982	Faber	Quiet Capital & 7 more

Access funding benchmarks and valuations. Sign up today!

View details of iLoF's funding rounds and investors

The founders of iLoF is Joana S Paiva. Luis Valente is the CEO of iLoF.

Here are the details of iLoF's key team members:

Joana S Paiva: Founder & CTO of iLoF.
Luis Valente: CEO of iLoF.
Contact Info: 2 email addresses

View details of iLoF's Founder profiles and Board Members

iLoF's employee count trend

iLoF has 42 employees as of Oct 26. Here is iLoF's employee count trend over the years:

Uncover iLoF's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of iLoF include Schrodinger, Recursion Pharmaceuticals and Relay Therapeutics. Here is the list of Top 10 competitors of iLoF, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	Gates, WuXi AppTec & 16 others	74/100
2nd	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, Felicis Ventures & 48 others	72/100
3rd	Relay Therapeutics 2016, Cambridge (United States), Public	Developer of drug discovery platform and study protein motion	$520M	BVF Partners, SoftBank Vision Fund & 17 others	70/100
4th	Atomwise 2012, San Francisco (United States), Series B	Developer of artificial intelligence platform for small molecule drug discovery	$219M	DCVC, B Capital & 27 others	67/100
5th	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	67/100
6th	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	SoftBank Vision Fund, Orbimed & 25 others	67/100
7th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	63/100
8th	In Silico 2014, Boston (United States), Public	AI-enabled bioinformatics platform for drug discovery and biomarker development	$510M	Qiming Venture Partners, Value Partners & 36 others	63/100
9th	Tandem AI 2021, New York (United States), Series A	AI-based drug discovery tool for researchers	$82M	Orbimed, Chengwei Capital & 4 others	62/100
10th	Genesis Therapeutics 2019, San Francisco (United States), Series B	Developer of an AI platform for discovering and designing novel drugs	$304M	Andreessen Horowitz, Rock Springs Capital ... & 16 others	62/100
32nd	iLoF 2019, Porto (Portugal), Series A	Developer of therapeutics for Alzheimer's disease	$5.09M	Alter Venture Partners, re.Mind Capital & 15 others	55/100